EMA/PE/0000240621 - paediatric investigation plan

lunsekimig

Key facts

• Active substance:
  lunsekimig
• Therapeutic area:
  Respiratory, thoracic and mediastinal disorders
• Decision number:
  EMA/PE/0000240621
• PIP number:
  EMA/PE/0000240621
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of nasal polyposis
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  16/05/2025
• Compliance check done:
  Nu

Decision

EMA/PE/0000240621 : EMA decision of 16 May 2025 on the granting of a product specific waiver for lunsekimig

Adopted Reference Number: EMADOC-1700519818-2114010